PTC Therapeutics
PTCT
PTCT
261 hedge funds and large institutions have $4.03B invested in PTC Therapeutics in 2025 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 86 increasing their positions, 93 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
261
Holders Change
+23
Holders Change %
+9.66%
% of All Funds
3.55%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.08%
New
51
Increased
86
Reduced
93
Closed
25
Calls
$15.8M
Puts
$12.5M
Net Calls
+$3.3M
Net Calls Change
+$20.9M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$60.8M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$37.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$36.2M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$32.2M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$32M |
Top Sellers
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$86.6M |
| 2 |
AC
Armistice Capital
New York
|
-$48.1M |
| 3 |
Blackstone Inc
New York
|
-$47.8M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$40.3M |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$34.3M |
